Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: The Business Research Company | PRODUCT CODE: 1518320

Cover Image

PUBLISHER: The Business Research Company | PRODUCT CODE: 1518320

Genomics Personalized Health Global Market Report 2024

PUBLISHED:
PAGES: 175 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
PDF (Single User License)
USD 4000
PDF (Site License)
USD 6000
PDF (Enterprise License)
USD 8000

Add to Cart

Genomics personalized health involves customizing medical care and treatments based on an individual's genomic data, taking into account their specific genetic characteristics, lifestyle choices, and environmental factors. This method utilizes progress in genomics, bioinformatics, and personalized medicine to offer more accurate and efficient healthcare solutions personalized to each person's genetic inclinations, susceptibilities, and responses to treatment.

The primary test types of genomics personalized health comprise oncology testing, infectious disease testing, orphan disease testing, autoimmune disease testing, obstetrics testing, and others. Oncology testing involves employing genetic testing methods to identify cancer and ascertain its unique attributes, utilizing technologies such as NGS platforms, RT-PCR, microarray, and genetic analyzers. These tests cater to end users such as academic research institutes, diagnostic centers, and others.

The genomics personalized health market research report is one of a series of new reports from The Business Research Company that provides genomics personalized health market statistics, including the genomics personalized health industry global market size, regional shares, competitors with genomics personalized health market share, detailed genomics personalized health market segments, market trends, and opportunities, and any further data you may need to thrive in the genomics personalized health industry. These genomics personalized health market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The genomics personalized health market size has grown rapidly in recent years. It will grow from $13.79 billion in 2023 to $15.97 billion in 2024 at a compound annual growth rate (CAGR) of 15.8%. The growth in the historic period can be attributed to government funding and support, advancements in genomics research, a rise in chronic diseases, technological innovations, and pharmaceutical industry investments.

The genomics personalized health market size is expected to see rapid growth in the next few years. It will grow to $29.00 billion in 2028 at a compound annual growth rate (CAGR) of 16.1%. The expansion projected for the forecast period can be credited to heightened healthcare investments, wider acceptance of genomics technologies, broader utilization of personalized medicine, an uptick in genetic disorders' prevalence, the enlargement of biobanks, and the increasing incidence of chronic diseases. Significant trends during this period encompass the merging with wearable technology, the proliferation of direct-to-consumer genetic testing, progressions in CRISPR and gene editing, amalgamation of genomics with digital health, and the extension of precision medicine initiatives.

The increasing interest in personalized medicine is poised to drive the expansion of the genomics personalized health market in the future. Personalized medicine, also referred to as precision medicine, revolutionizes healthcare by customizing medical interventions to suit the unique characteristics of individual patients. The surge in demand for personalized medicine stems from a transition towards preventive healthcare, enhanced treatment outcomes, heightened patient involvement and empowerment, economic advantages, and the escalating prevalence of chronic and intricate ailments. Genomics personalized health plays a pivotal role in advancing personalized medicine by harnessing individual genetic data to tailor medical interventions, spanning from preventive measures and diagnosis to treatment and monitoring. For example, in February 2024, as reported by the Personalized Medicine Coalition, a non-profit organization based in the US, the Food and Drug Administration (FDA) sanctioned 16 innovative personalized therapies for rare diseases in 2023, in contrast to six in 2022. Hence, the escalating demand for personalized medicine underpins the growth of the genomics personalized health market.

Major players in the genomics personalized health market are concentrating on pioneering product development, exemplified by the creation of next-generation sequencing benchtop sequencers, aimed at securing a competitive advantage. Next-generation sequencing (NGS) benchtop sequencers are compact, high-throughput sequencing platforms that scrutinize an individual's genetic blueprint to guide decisions and interventions in genomics personalized healthcare. For example, in December 2021, Singular Genomics Sys, a US-based life science technology firm, introduced its next-generation sequencing (NGS) G4 benchtop sequencer for commercial applications across diverse fields such as oncology and immunology research. The G4 boasts exclusive chemistry for precise sequencing, accommodating up to 16 samples simultaneously, swift operational durations, and a data output per hour up to threefold higher than other benchtop instruments. Key specifications include data output ranging from 15-400 gigabases (Gb) per run, operational durations spanning 6-19 hours, and accuracy rates of 99.6-99.9% across all kits.

In January 2022, Exact Sciences Corp., a US-based biotechnology research company, completed the acquisition of PreventionGenetics for an undisclosed sum. This strategic move was intended to enhance Exact Sciences' capabilities in cancer screening and diagnostics, with a specific focus on hereditary cancer testing, in order to further the cause of personalized healthcare and promote early cancer detection. PreventionGenetics, also based in the US, is a biotechnology research company specializing in genomics personalized health.

Major companies operating in the genomics personalized health market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Quest Diagnostics, Agilent Technologies Inc., Lonza Group, PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., Exact Sciences Corporation, QIAGEN N.V, Natera Inc., Adaptive Biotechnologies Corporation, Myriad Genetics Inc., NanoString Technologies Inc., Pacific Biosciences of California Inc., Personalis Inc., DNA Genotek Inc., Twist Bioscience Corporation, GRAIL Inc., Eastern Biotech and Life Sciences, INVITAE Corporation, Genetic Technologies Limited, XCode Life Sciences Private Limited, Biome Inc., BGI Genomics Co. Ltd.

North America was the largest region in the personalized health market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genomics personalized health market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the genomics personalized health market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The genomics personalized health market consists of revenues earned by entities by providing services such as genomic sequencing, bioinformatics analysis, genetic testing, and consulting services. The market value includes the value of related goods sold by the service provider or included within the service offering. The genomics personalized health market also includes sales of DNA sequencing kits, genomic data management solutions, pharmacogenomics tests, personalized wellness and nutrition products, and companion diagnostics. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Genomics Personalized Health Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on genomics personalized health market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for genomics personalized health ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The genomics personalized health market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Test Type: Oncology Testing; Infectious Disease Testing; Orphan Disease Testing; Autoimmune Disease Testing; Obstetrics Testing; Other Test Type
  • 2) By Technology: NGS platforms; RT-PCR; Microarray; Genetic Analyzers
  • 3) By End User: Academic Research Institutes; Diagnostic Centers; Other End Users
  • Companies Mentioned: F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Quest Diagnostics; Agilent Technologies Inc.; Lonza Group
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.
Product Code: r18365

Table of Contents

1. Executive Summary

2. Genomics Personalized Health Market Characteristics

3. Genomics Personalized Health Market Trends And Strategies

4. Genomics Personalized Health Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Genomics Personalized Health Market Size and Growth

  • 5.1. Global Genomics Personalized Health Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Genomics Personalized Health Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Genomics Personalized Health Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Genomics Personalized Health Market Segmentation

  • 6.1. Global Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oncology Testing
  • Infectious Disease Testing
  • Orphan Disease Testing
  • Autoimmune Disease Testing
  • Obstetrics Testing
  • Other Test Type
  • 6.2. Global Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • NGS platforms
  • RT-PCR
  • Microarray
  • Genetic Analyzers
  • 6.3. Global Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Academic Research Institutes
  • Diagnostic Centers
  • Other End User

7. Genomics Personalized Health Market Regional And Country Analysis

  • 7.1. Global Genomics Personalized Health Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Genomics Personalized Health Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Genomics Personalized Health Market

  • 8.1. Asia-Pacific Genomics Personalized Health Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Genomics Personalized Health Market

  • 9.1. China Genomics Personalized Health Market Overview
  • 9.2. China Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Genomics Personalized Health Market

  • 10.1. India Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Genomics Personalized Health Market

  • 11.1. Japan Genomics Personalized Health Market Overview
  • 11.2. Japan Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Genomics Personalized Health Market

  • 12.1. Australia Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Genomics Personalized Health Market

  • 13.1. Indonesia Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Genomics Personalized Health Market

  • 14.1. South Korea Genomics Personalized Health Market Overview
  • 14.2. South Korea Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Genomics Personalized Health Market

  • 15.1. Western Europe Genomics Personalized Health Market Overview
  • 15.2. Western Europe Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Genomics Personalized Health Market

  • 16.1. UK Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Genomics Personalized Health Market

  • 17.1. Germany Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Genomics Personalized Health Market

  • 18.1. France Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Genomics Personalized Health Market

  • 19.1. Italy Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Genomics Personalized Health Market

  • 20.1. Spain Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Genomics Personalized Health Market

  • 21.1. Eastern Europe Genomics Personalized Health Market Overview
  • 21.2. Eastern Europe Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Genomics Personalized Health Market

  • 22.1. Russia Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Genomics Personalized Health Market

  • 23.1. North America Genomics Personalized Health Market Overview
  • 23.2. North America Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Genomics Personalized Health Market

  • 24.1. USA Genomics Personalized Health Market Overview
  • 24.2. USA Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Genomics Personalized Health Market

  • 25.1. Canada Genomics Personalized Health Market Overview
  • 25.2. Canada Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Genomics Personalized Health Market

  • 26.1. South America Genomics Personalized Health Market Overview
  • 26.2. South America Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Genomics Personalized Health Market

  • 27.1. Brazil Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Genomics Personalized Health Market

  • 28.1. Middle East Genomics Personalized Health Market Overview
  • 28.2. Middle East Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Genomics Personalized Health Market

  • 29.1. Africa Genomics Personalized Health Market Overview
  • 29.2. Africa Genomics Personalized Health Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Genomics Personalized Health Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Genomics Personalized Health Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Genomics Personalized Health Market Competitive Landscape And Company Profiles

  • 30.1. Genomics Personalized Health Market Competitive Landscape
  • 30.2. Genomics Personalized Health Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche AG
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Thermo Fisher Scientific Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Quest Diagnostics
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Agilent Technologies Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Lonza Group
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Genomics Personalized Health Market Other Major And Innovative Companies

  • 31.1. PerkinElmer Inc.
  • 31.2. Illumina Inc.
  • 31.3. Bio-Rad Laboratories Inc.
  • 31.4. Exact Sciences Corporation
  • 31.5. QIAGEN N.V
  • 31.6. Natera Inc.
  • 31.7. Adaptive Biotechnologies Corporation
  • 31.8. Myriad Genetics Inc.
  • 31.9. NanoString Technologies Inc.
  • 31.10. Pacific Biosciences of California Inc.
  • 31.11. Personalis Inc.
  • 31.12. DNA Genotek Inc.
  • 31.13. Twist Bioscience Corporation
  • 31.14. GRAIL Inc.
  • 31.15. Eastern Biotech and Life Sciences

32. Global Genomics Personalized Health Market Competitive Benchmarking

33. Global Genomics Personalized Health Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Genomics Personalized Health Market

35. Genomics Personalized Health Market Future Outlook and Potential Analysis

  • 35.1 Genomics Personalized Health Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Genomics Personalized Health Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Genomics Personalized Health Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!